Advanced Biomed Inc. (ADVB): Total Liabilities

Annual figures by period end, from SEC filings.

$1.47M
As of 2026-06-30
$1.61M
As of 2026-09-30
$19.38M2024-06-30: $2.80M2025-06-30: $19.38M2026-06-30: $1.47M$1.47M
2024-06-30 Total Liabilities (USD) 2026-06-30
Period endedTotal LiabilitiesChange YoYSource filing
2026-06-30$1.47M-92.4%2026-10-13, Balance as of period end
2025-06-30$19.38M+593.0%2026-10-13, Balance as of period end
2024-06-30$2.80Mn/a2025-10-08, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Advanced Biomed Inc. (ADVB)2026-06-30$1.47M-92.4%
YD Bio Ltd (YDES)2025-12-31$16.64Mn/m
Aclarion, Inc. (ACON)2025-12-31$837.3K-27.4%
BioNexus Gene Lab Corp (BGLC)2025-12-31$637.9K-69.8%
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31$43.58M+17.8%
American Shared Hospital Services (AMS)2025-12-31$27.79M-7.9%
Exagen Inc. (XGN)2025-12-31$40.57M+15.4%
Biodesix Inc (BDSX)2025-12-31$89.94M+17.8%
Freenome, Inc. (FRNM)2025-12-31$5.70M+55.8%

Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗